Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I have an MBA as well, but until you are in the situations where you need to wear the big boy (girl) pants it doesn't mean much.
Mine is in finance and I wouldn't let me be CFO. You need to practice the craft and the Doc is more versed as a scientist. Nothing wrong with that -- just get someone in that is experienced in the areas you don't know.
Pretty simple: Hope is not a plan.
That's my question. I know Tim had a strong answer for people regarding Phase 3 on clinicaltrials.gov. As I read the information on the links below it seems like the study should be available.
I could be wrong, so a second set of eyes or an expert in the field would be helpful to explain.
Thanks.
https://clinicaltrials.gov/ct2/manage-recs/faq#fr_30
https://www.bumc.bu.edu/ohra/clinicaltrials-gov/clinicaltrials-gov-what-why-which-studies-when/
I completely agree. Need a change in leadership, but that won't happen. Best outcome is that a bigger player likes the IP and buys them out.
Yes, but I can't give ENZC a free pass on this. Tom was chosen to do PR. His activity reflects the company. If you really don't have concrete info then don't act like just another pumper.
I've said this before, if you want to be taken seriously then act that way.
I don't think dipping below .06 will be a disaster per se. Unfortunately, it's part of the slow motion train wreck -- just another milestone on the way down.
With continued no news, missed milestones, etc I see this continuing to go down little by little.
And this is why I’m upset with management. It’s been 9 months. It’s not that they didn’t reach IND filings but it’s that I don’t recall any updates, schedule, etc.
Why would this stock go up?
I'm sorry but does anyone have a link to the phase 3 study? I can't find it anywhere.
I was unable to download to read details. Does this outcome surprise anyone? Hard to prove this stuff.
The other has been a painful education regarding the phase 3 process for me. The power of BP is astonishing.
Tough for the little guys. Best case seems to be licensing or buyout.
Not sure if it’s ok to publish that on the board. I don’t want to be seen as pumping another stock.
Just google bucillamine.
I really want to invest in this but the fact that I can’t find Phase 3 info is troubling. I have another OTC with a phase 3 and have been following along with the progress. That’s my expectation for TSOI too.
With a quiet period I would think you are right. Nothing to prop up the price.
Agree. I watched the short podcast today. Nothing new. Now entering quiet period. Tbh a little disappointed. Halfway through what was supposed to be an eventful summer,
Probably a lot going on but doesn’t feel like a liquidity event is imminent.
Thanks. I’ve been taking Quadramune for 3.5 months. Don’t really feel different but haven’t been sick.
My dad 85 is concerned about memory issues and I suggested NuBrainer.
Does anyone have any first hand experience with NuBrainer? I'd be interested to hear your results/improvements.
I still don’t understand the excitement around an NDA. I sign several throughout the year in my line of work and all it means is that we are free to discuss things. It doesn’t actually mean you are going to move forward with anything. You might…but no guarantee.
I’d much rather anticipate some results from Africa or get an update from Samsung.
Can you please share with the board?
Agreed but I’d like him to start frying them…or at least prepping the fish
I thought Ken said there would be more announcements for last week. Did I misunderstand that comment to shareholders or did I miss an announcement? I was expecting a PR.
Any help?
I hope I’m wrong but I don’t think he NDA lift will do anything for SP. Perhaps they will talk about a partnership but unless it’s BP saying they are buying ENZC or will be granted licensing it might not move the needle. I’d rather have an update on results from Africa.
Leadership needs to come through instead of the fluff we’ve been hearing.
Enter the Dragon
"Never take your eye off your opponent"
This is interesting and disturbing at the same time. Not sure if buc would be safe for babies.
https://www.dailymail.co.uk/news/article-10958689/Covid-19-Australia-Pandemic-babies-no-immunity-viruses-ending-ICU.html
I’m sorry. I enjoy most of the comments and learn from many on here. But, to criticize the use of “adding some color” is flat out silly. I hear that phrase daily in meetings and is used as a nice way to transition to another person who may have something to add.
Criticize the strategy and results but not necessary to dissect every nuance and phrase IMO.
You guys are better than that…whether short or long on the stock.
Very encouraging to hear revenue coming in.
If what Tom does is considered “PR” I think I could do that job.
Same pattern…he and Doc throw out some hashtags and builds expectations and then an actual release comes that never meets the hype.
I enjoy the podcasts but I want to hear about a liquidity event actually occurring or at least news that they are booking revenue for their new product.
Regarding #4, I can’t remember for sure but I thought they were planning on adding a couple of SaaS customers a month.
Anyone confirm? If so, I’d like to hear how that’s progressing.
I’ve grown to not trust anything from this management team or the PR group. I don’t think they are scammers just not properly equipped to deliver. Selling the company would be best at this point.
I think we’re all anxious for a liquidity event and an update on any revenue information for their newly released product.
It won't go anywhere but down until there's a liquidity event.
CC has shown he needs help. A buyout would be best. The IP is impressive but won’t mean much if you can’t commercialize.
Appreciate this post and Dales breaking it down. Anyone waiting might want to hop on quickly
I should say I take 2/day.
I’ve been using for 4 months. I haven’t really noticed any impact. I haven’t been ill but I don’t know if that’s been aided by the product or not. In general I don’t get sick that often. My plan is to see if there’s any impact on blood work in a few months.
Inflammation is being identified as such a problem I’m willing to continue to use.
That’s all it is - opinion. Lots of people on this forum with more experience than I have.
Following the board for a while now, I have noticed the natives are getting restless.
Be great to see it head the right direction.
I don’t think these guys are frauds. I think they are trying but just don’t know what they are doing when it comes to being a public company. As part of the leadership team, words mean something. Yes, it’s OTC but they are trying to be something more. They are trying to change the world. Start acting like that.
In regards to the audit and IPF, neither will impact the share price much. They have OTC peers selling through Amazon already (TS*I) and also have drugs in Phase 3. Share price is still less than 0.05. It’s going to take a long time and Clone 3 is the big one to me. That’s the game changer.
Just my opinion. I want them to succeed and for those on this board to enjoy a windfall. I’m staying long because it’s house money.
I believe Ken mentioned this filing would be coming and was proactively done. Perhaps someone else can confirm.
it does seem like we have plenty of time to file this as the share price has a long way to .05 unless liquidity events start happening.
It’s hard not to agree with you. What upsets me is that this drug has been around forever and it appears to make a difference. How many lives might have been saved?
Makes you wonder if something like Prilosec helped with covid if the FDA would stand in he way.
My cynicism regarding the process has grown seeing how this has progressed.